An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
ANI Pharmaceuticals, Inc. (ANIP) announced that its CEO and CFO will participate in two upcoming healthcare conferences in New York City. The first event is Capital One 1st Annual Biotech/Biopharma Disruptors on May 14, 2024, and the second is H.C. Wainwright 2nd Annual BioConnect Conference at NASDAQ on May 20, 2024. Investors can schedule 1x1 meetings with management via provided contacts. The webcast of the events will be available on ANIP's website for 90 days.
ANI Pharmaceuticals, Inc. (ANIP) ha annunciato la partecipazione del suo CEO e CFO a due conferenze sanitarie imminenti a New York City. Il primo evento, Capital One 1st Annual Biotech/Biopharma Disruptors, si terrà il 14 maggio 2024, mentre il secondo, H.C. Wainwright 2nd Annual BioConnect Conference, avrà luogo presso il NASDAQ il 20 maggio 2024. Gli investitori potranno pianificare incontri individuali con la direzione tramite i contatti forniti. La trasmissione web degli eventi sarà disponibile sul sito di ANIP per 90 giorni.
ANI Pharmaceuticals, Inc. (ANIP) ha anunciado que su CEO y CFO participarán en dos próximas conferencias de salud en la Ciudad de Nueva York. El primer evento es el Capital One 1st Annual Biotech/Biopharma Disruptors el 14 de mayo de 2024 y el segundo es la H.C. Wainwright 2nd Annual BioConnect Conference en el NASDAQ el 20 de mayo de 2024. Los inversores pueden programar reuniones individuales con la gerencia a través de los contactos proporcionados. La retransmisión de los eventos estará disponible en el sitio web de ANIP durante 90 días.
ANI Pharmaceuticals, Inc. (ANIP)가 CEO와 CFO가 뉴욕시에서 열리는 두 건강 관련 컨퍼런스에 참여할 예정이라고 발표했습니다. 첫 번째 행사인 Capital One 제1회 Biotech/Biopharma Disruptors 컨퍼런스는 2024년 5월 14일에, 두 번째 행사인 H.C. Wainwright 제2회 BioConnect 컨퍼런스는 2024년 5월 20일에 NASDAQ에서 개최됩니다. 투자자들은 제공된 연락처를 통해 경영진과 1대1 미팅을 예약할 수 있습니다. 이벤트의 웹캐스트는 ANIP의 웹사이트에서 90일 동안 제공될 예정입니다.
ANI Pharmaceuticals, Inc. (ANIP) a annoncé que son PDG et son CFO participeront à deux conférences de santé prochaines à New York City. Le premier événement, Capital One 1st Annual Biotech/Biopharma Disruptors, se tiendra le 14 mai 2024, et le second, la H.C. Wainwright 2nd Annual BioConnect Conference, aura lieu au NASDAQ le 20 mai 2024. Les investisseurs peuvent planifier des rencontres individuelles avec la direction via les contacts fournis. La diffusion web des événements sera disponible sur le site d'ANIP pendant 90 jours.
ANI Pharmaceuticals, Inc. (ANIP) hat angekündigt, dass sowohl der CEO als auch der CFO an zwei bevorstehenden Gesundheitskonferenzen in New York City teilnehmen werden. Die erste Veranstaltung, die Capital One 1st Annual Biotech/Biopharma Disruptors, findet am 14. Mai 2024 statt und die zweite, die H.C. Wainwright 2nd Annual BioConnect Conference, wird am 20. Mai 2024 am NASDAQ durchgeführt. Investoren können über die bereitgestellten Kontakte Einzelgespräche mit der Geschäftsführung vereinbaren. Die Webübertragung der Veranstaltungen ist für 90 Tage auf der Website von ANIP verfügbar.
Positive
None.
Negative
None.
BAUDETTE, Minn., May 01, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will participate at two upcoming healthcare conferences in New York City as follows:
Capital One 1st Annual Biotech/Biopharma Disruptors Event
H.C. Wainwright 2nd Annual BioConnect Conference at NASDAQ
Date:
Monday, May 20, 2024
Time:
9:00am ET
Webcast:
Click Here
To schedule a 1x1 meeting with management, please contact meetings@hcwco.com.
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high-quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. The Company is focused on delivering sustainable growth by scaling up its Rare Disease business through its lead asset Purified Cortrophin® Gel, strengthening its Generics business with enhanced research and development capabilities, leveraging its U.S. based manufacturing footprint, and delivering innovation in Established Brands. For more information, please visit our website www.anipharmaceuticals.com.
Investor Relations: Lisa M. Wilson, In-Site Communications, Inc.
When will ANI Pharmaceuticals participate in healthcare conferences in New York City?
ANI Pharmaceuticals will participate in two upcoming healthcare conferences in New York City. The Capital One 1st Annual Biotech/Biopharma Disruptors event is on May 14, 2024, and the H.C. Wainwright 2nd Annual BioConnect Conference at NASDAQ is on May 20, 2024.
Who will represent ANI Pharmaceuticals at the healthcare conferences in New York City?
Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will represent ANI Pharmaceuticals at the upcoming healthcare conferences in New York City.
How can investors schedule a meeting with ANI Pharmaceuticals management during the conferences?
Investors can schedule 1x1 meetings with ANI Pharmaceuticals management by contacting kristen.patrick@capitalone.com for the Capital One event and meetings@hcwco.com for the H.C. Wainwright event.
Where can I access the webcast of the healthcare conferences?
The live and archived webcast of the healthcare conferences will be accessible on ANI Pharmaceuticals' website at www.anipharmaceuticals.com under the Investors section and Events and Presentations. The webcast will be available for 90 days.
ani pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. we focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. our two pharmaceutical manufacturing facilities located in baudette, minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize cortrophin gel and cortrophin-zinc.
